DE3044542A1 - Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents
Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittelInfo
- Publication number
- DE3044542A1 DE3044542A1 DE19803044542 DE3044542A DE3044542A1 DE 3044542 A1 DE3044542 A1 DE 3044542A1 DE 19803044542 DE19803044542 DE 19803044542 DE 3044542 A DE3044542 A DE 3044542A DE 3044542 A1 DE3044542 A1 DE 3044542A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- general formula
- müller
- hydrogen atom
- syn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims description 4
- 229940126601 medicinal product Drugs 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 239000012965 benzophenone Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000005191 hydroxyalkylamino group Chemical group 0.000 claims description 2
- 238000005744 Teer Meer reaction Methods 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004455 differential thermal analysis Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- FIAINKIUSZGVGX-UHFFFAOYSA-N (1-amino-1-oxopropan-2-yl)azanium;chloride Chemical compound Cl.CC(N)C(N)=O FIAINKIUSZGVGX-UHFFFAOYSA-N 0.000 description 1
- ZUWXHHBROGLWNH-UHFFFAOYSA-N (2-amino-5-chlorophenyl)-phenylmethanone Chemical compound NC1=CC=C(Cl)C=C1C(=O)C1=CC=CC=C1 ZUWXHHBROGLWNH-UHFFFAOYSA-N 0.000 description 1
- WKNMKGVLOWGGOU-UHFFFAOYSA-N 2-aminoacetamide;hydron;chloride Chemical compound Cl.NCC(N)=O WKNMKGVLOWGGOU-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- -1 amine compound Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7929139A FR2470116A1 (fr) | 1979-11-27 | 1979-11-27 | Derives benzylideniques, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3044542A1 true DE3044542A1 (de) | 1981-09-03 |
Family
ID=9232118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19803044542 Withdrawn DE3044542A1 (de) | 1979-11-27 | 1980-11-26 | Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5692852A (enExample) |
| AT (1) | AT372077B (enExample) |
| AU (1) | AU535262B2 (enExample) |
| BE (1) | BE886361A (enExample) |
| CA (1) | CA1145760A (enExample) |
| DE (1) | DE3044542A1 (enExample) |
| DK (1) | DK503180A (enExample) |
| ES (1) | ES8107168A1 (enExample) |
| FR (1) | FR2470116A1 (enExample) |
| GB (1) | GB2063867B (enExample) |
| GR (1) | GR72133B (enExample) |
| IL (1) | IL61568A (enExample) |
| IT (1) | IT1134469B (enExample) |
| LU (1) | LU82958A1 (enExample) |
| NL (1) | NL8006427A (enExample) |
| NO (1) | NO803561L (enExample) |
| NZ (1) | NZ195654A (enExample) |
| PT (1) | PT72114B (enExample) |
| SE (1) | SE8008279L (enExample) |
| ZA (1) | ZA807389B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8220421A (nl) * | 1982-07-30 | 1984-06-01 | Inst Organicheskogo Sinteza Ak | Condensatieprodukten van alfa-aminoisopropylfenylketon bij de carbonyl c=o binding met gesubstitueerde amines van functioneel gesubstitueerde hydrazines of met derivaten van in de natuur voorkomende aminozuren, die een antitumoractiviteit hebben. |
| US5278191A (en) * | 1988-08-31 | 1994-01-11 | G. D. Searle & Co. | Diphenylmethylaminoacetamide derivatives as anti-convulsants |
| EP4627902A3 (en) | 2018-09-14 | 2026-01-14 | Precision Planting LLC | Fluid control assembly and system |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1497456A (fr) * | 1964-06-15 | 1967-10-13 | Clin Byla Ets | Ortho-amino aryl cétimines, composés hétérocycliques qui s'y rattachent et prépaation de ces divers corps |
-
1979
- 1979-11-27 FR FR7929139A patent/FR2470116A1/fr active Granted
-
1980
- 1980-11-26 NZ NZ195654A patent/NZ195654A/xx unknown
- 1980-11-26 AT AT0577780A patent/AT372077B/de active
- 1980-11-26 NO NO803561A patent/NO803561L/no unknown
- 1980-11-26 CA CA000365550A patent/CA1145760A/en not_active Expired
- 1980-11-26 IL IL61568A patent/IL61568A/xx unknown
- 1980-11-26 NL NL8006427A patent/NL8006427A/nl not_active Application Discontinuation
- 1980-11-26 IT IT26247/80A patent/IT1134469B/it active
- 1980-11-26 GR GR63468A patent/GR72133B/el unknown
- 1980-11-26 ES ES497146A patent/ES8107168A1/es not_active Expired
- 1980-11-26 PT PT72114A patent/PT72114B/pt unknown
- 1980-11-26 JP JP16736380A patent/JPS5692852A/ja active Pending
- 1980-11-26 GB GB8037869A patent/GB2063867B/en not_active Expired
- 1980-11-26 DE DE19803044542 patent/DE3044542A1/de not_active Withdrawn
- 1980-11-26 AU AU64730/80A patent/AU535262B2/en not_active Ceased
- 1980-11-26 DK DK503180A patent/DK503180A/da not_active Application Discontinuation
- 1980-11-26 LU LU82958A patent/LU82958A1/fr unknown
- 1980-11-26 ZA ZA00807389A patent/ZA807389B/xx unknown
- 1980-11-26 BE BE0/202944A patent/BE886361A/fr not_active IP Right Cessation
- 1980-11-26 SE SE8008279A patent/SE8008279L/ not_active Application Discontinuation
Non-Patent Citations (1)
| Title |
|---|
| NICHTS-ERMITTELT * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES497146A0 (es) | 1981-10-01 |
| IT8026247A0 (it) | 1980-11-26 |
| AT372077B (de) | 1983-08-25 |
| FR2470116A1 (fr) | 1981-05-29 |
| IL61568A0 (en) | 1980-12-31 |
| DK503180A (da) | 1981-05-28 |
| IT1134469B (it) | 1986-08-13 |
| NL8006427A (nl) | 1981-07-01 |
| AU535262B2 (en) | 1984-03-08 |
| GB2063867A (en) | 1981-06-10 |
| BE886361A (fr) | 1981-05-26 |
| LU82958A1 (fr) | 1982-06-30 |
| ZA807389B (en) | 1981-11-25 |
| GB2063867B (en) | 1983-09-14 |
| FR2470116B1 (enExample) | 1983-07-18 |
| PT72114A (fr) | 1980-12-01 |
| AU6473080A (en) | 1981-06-04 |
| JPS5692852A (en) | 1981-07-27 |
| PT72114B (fr) | 1981-09-29 |
| NO803561L (no) | 1981-05-29 |
| GR72133B (enExample) | 1983-09-19 |
| SE8008279L (sv) | 1981-05-28 |
| IL61568A (en) | 1984-12-31 |
| ES8107168A1 (es) | 1981-10-01 |
| ATA577780A (de) | 1983-01-15 |
| NZ195654A (en) | 1982-05-31 |
| CA1145760A (en) | 1983-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2924681A1 (de) | Phenylpiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE3633861A1 (de) | Neue imidazo-benzoxazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel | |
| DE2720085C2 (enExample) | ||
| DE69106746T2 (de) | Imidazo[1,2-c]chinazolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
| EP0058341A1 (de) | Azepinderivate, ihre Herstellung und diese enthaltende Arzneimittel | |
| EP0053767A1 (de) | Tricyclische Cytosinderivate zur Verwendung in Arzneimitteln und Verfahren zu ihrer Herstellung | |
| EP0003029A2 (de) | Neue 2-Oxo-1-pyrrolidinessigsäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel und deren Herstellung | |
| EP0019172B1 (de) | 6-Substituierte 11-Alkylen-morphantridine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel | |
| EP0173933B1 (de) | 1,6-Naphthyridin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE3044542A1 (de) | Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel | |
| DE2535599C2 (de) | Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten | |
| DE2223681A1 (de) | Neue heterocyclische Verbindungen und Verfahren zu ihrer Herstellung | |
| EP0190563B1 (de) | Neue 12-Amino-pyridazino[4',5':3,4]pyrrolo-[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE3321674A1 (de) | Neues pyrazolopyridinderivat | |
| DE3879378T2 (de) | Amid-verbindungen. | |
| DE2403786A1 (de) | Neue derivate der cumarine | |
| DE2716172C2 (de) | Bis(6-[(hexahydro-1H-azepin-1-yl)-methylenamino]-penicillanoyloxy)-methan, seine Herstellung und dieses enthaltendes Arzneimittel | |
| DE1620295B2 (de) | Isochinolo eckige Klammer auf 2,1-d eckige Klammer zu benzo eckige Klammer auf 1,4 eckige Klammer zu diazepin-6-one | |
| EP0054839A2 (de) | 2-Acylaminomethyl-1,4-benzodiazepine und deren Salze sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE3709699C2 (de) | 5-Fluoruracil-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2949395A1 (de) | Verwendung von substituierten chinazolinen zur behandlung von hochdruck und bradykardie sowie als kardiotone wirkstoffe | |
| DE2520131A1 (de) | Stickstoffhaltige polycyclische verbindungen und verfahren zu deren herstellung | |
| DE2435381C2 (de) | 8-(2-Dimethylaminoäthyl)-3-oxo-4-phenyl-1-thia-4,8-diazaspiro[4.5]decan und seine Salze mit Säuren, Verfahren zu ihrer Herstellung und deren Verwendung in Arzneipräparaten | |
| DE2733869C2 (de) | 2-Carbamoyl-1,2,4,5-tetrahydro-3H-2-benzazepin-3-one, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| EP0111205B1 (de) | Acridanon-Derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| 8181 | Inventor (new situation) |
Free format text: KAPLAN, JEAN-PIERRE, CHEVILLY LARUE, FR RAIZON, BERNARD, VIGNEUX, FR |
|
| 8136 | Disposal/non-payment of the fee for publication/grant |